Dr. Candace Cheng, who manages Obermatt’s US stock portfolio, has already bought a couple of healthcare stocks, like Quest Diagnostics and LabCorp and they already performed well, so she decided to buy two more. Teladoc, a new player in the field of telemedicine that Obermatt still doesn’t cover - because she likes their product, and Hologic - because female health is an important issue.